Tubeless insulin pump market seen nearly doubling by 2030

The global tubeless insulin pump market was valued at $2.2 billion in 2025 and is projected to reach $5.28 billion by 2030, driven by rising diabetes cases, wearable tech adoption and wider use of remote monitoring. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Tubeless insulin pumps offer a less intrusive way to deliver insulin, which can improve comfort and make diabetes management easier for patients. - The market’s projected rise signals growing demand for connected, wearable diabetes technologies as diabetes prevalence keeps climbing. - Download a free sample of the market report or view the full market report.

What happened: - The Business Research Company released a 2026 intelligence report on the tubeless insulin pump market. - The report values the market at $2.2 billion in 2025. - The report projects the market will reach $2.63 billion in 2026, implying 19.3% annual growth. - The forecast puts the market at $5.28 billion by 2030, with a 19.0% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - A tubeless insulin pump is a compact wearable device that delivers insulin continuously without external tubing. - The device adheres directly to the skin and wirelessly connects to a handheld controller. - The report cites limited availability of tubeless pumps, continued reliance on conventional insulin delivery systems, rising diabetes incidence, greater hospital adoption of insulin pumps and early use of basic continuous glucose monitoring systems as historical growth drivers. - The report points to wearable and implantable insulin pump advances, AI integration, smart monitoring, remote patient monitoring, patient awareness, and e-commerce and telemedicine growth as future drivers. - The report highlights wearables, continuous glucose monitoring integration, Bluetooth-enabled and remote-controlled pumps, disposable and reusable patch pumps, and online distribution as key trends. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The report’s focus on AI, remote monitoring and telemedicine suggests the market is shifting toward more connected diabetes care. - The emphasis on online distribution and Bluetooth-enabled devices points to a consumer preference for convenience and lower-friction device management. - The diabetes growth forecast from the Institute for Health Metrics and Evaluation underscores why insulin delivery devices remain a priority category. - In June 2023, the Institute for Health Metrics and Evaluation said more than 500 million people worldwide were living with diabetes and projected that figure could reach about 1.3 billion by 2050.

What's next: - Market growth will likely depend on how quickly manufacturers expand wearable features, remote control functions and CGM integration. - Wider adoption in Asia-Pacific could narrow the gap with North America if healthcare access and device availability improve. - The shift toward digital distribution and telemedicine may reshape how patients access insulin delivery products.

The bottom line: - Tubeless insulin pumps are moving from a niche diabetes tool toward a fast-growing connected health category, with strong demand expected through 2030.